Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Tax loss done
View:
Post by DIYGuy on Dec 27, 2017 4:43pm

Tax loss done

That should be it for the tax loss selling. After a big year in the market it made sense for people to sell to offset their gains in open accounts. That no longer applies. No need to give shares away anymore.

It will be interesting to see if now see a steady news flow. I guess the deal with the US investment bank removes some of the doubt about access to future capital to fund the clinical trials as they progress into the expansion and combination trials once the MTD is found for HNSCC. Would be interested in some information on how this relationship will work.

Happy New Year to all and looking forward to a much better 2018!
Comment by DIYGuy on Jan 04, 2018 7:47am
So, what do I know? Apparently not much.  See link for AGM presentation. Slide 10 is what I am always going on about and they put it right there in the presentation. Slide 11 gives us a timeline. Looks like we need cash again. If that 5MM US comes in or partnership we will be able to fund the clinical trial. Until then, lots of uncertainty.  What’s the saying, “be greedy when others ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities